News
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
A decision is expected in the fourth quarter of 2025.
CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...
The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...
Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...
CVS and Novo Nordisk have struck a deal that will see the drugstore chain offering the Wegovy weight-loss drug to customers ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Novo Nordisk partners with telehealth ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results